Heart failure fluid battle: which pill works better?
NCT ID NCT07199088
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two water pills—acetazolamide and metolazone—added to standard diuretics in 320 adults hospitalized with acute decompensated heart failure. The goal is to see which drug clears fluid buildup faster and more safely, reducing hospital stays and complications. Participants receive one of the two pills daily, and doctors track decongestion, kidney function, and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- acetazolamide and metolazone (diuretic drugs)
- What this could lead to
- If it works, this could identify a better add-on diuretic to help heart failure patients get rid of excess fluid faster and shorten hospital stays.
- What could go wrong
- This is a single-center study in Pakistan, so results may not apply to other populations. Both drugs can cause kidney problems or electrolyte imbalances, and the trial is not blinded, which could bias results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Quaid e Azam Medical College , bahawalpur
RECRUITINGChak Four Hundred Fifty-four, Punjab Province, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single gene infusion rebuild failing hearts?
- Are heart failure patients taking their meds? a urine test at the ER aims to find out
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Can common heart drugs stay safe during a crisis? a trial investigates
- Virtual heart team aims to close medication gap for veterans with heart failure
- Heart failure fluid removal device trial halted early